StockData
Takeda Pharmaceutical Co Ltd logo

Takeda Pharmaceutical Co Ltd (TAK) stock

TAKNYSEPharmaceutical PreparationsAlso trades as TKPHF
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 17, 2026Score 5/30
$21.64+0.05 (+0.23%)

Close on Nov 17, 2026Market cap $74.58BP/E –Yield –

Takeda Pharmaceutical price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Takeda Pharmaceutical's price to book ratio was 1.4× on Nov 11, 2026, against 1.0× a year earlier. Over the last 5 years it ranged from 0.9× to 1.4×, with a median of 1.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.4×+0.3
2025Dec 31, 20251.1×+0.2
2024Dec 31, 20240.9×−0.1
2023Dec 29, 20231.0×−0.1
2022Dec 30, 20221.1×+0.2
2021Dec 31, 20211.0×−0.3
2020Dec 31, 20201.3×−0.0
2019Dec 31, 20191.3×−0.2
2018Dec 31, 20181.5×–

More Takeda Pharmaceutical figures

See a number that looks wrong?